23 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
event within [***] of the written request, the Technical Dispute will, at the request of either party, be referred for determination to an expert … in the following manner:
1. Appointment of Expert. Within [***] after a party requests under Section 12.2 of the Agreement that an expert be appointed
8-K
EX-1.1
EVOK
Evoke Pharma Inc
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
of Directors qualifies as an “audit committee financial expert,” as such term is defined under Regulation S-K and the listing rules of the Exchange
PRE 14A
b037y8ifz 51d
12 Mar 21
Preliminary proxy
8:30am
424B5
5yryn4w6c1dva0xutqjp
14 Jan 21
Prospectus supplement for primary offering
5:19pm
424B5
kwzuf
13 Jan 21
Prospectus supplement for primary offering
4:34pm